Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hereditary Angioedema (HAE) peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Hereditary Angioedema (HAE). The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
1 profiles.
2021–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 11 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hereditary Angioedema (HAE) unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01386658
PeptideScanner retained ClinicalTrials.gov record NCT01386658 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-08, and PeptideScanner's reviewed identity mapping was icatibant.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 8, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02045264
PeptideScanner retained ClinicalTrials.gov record NCT02045264 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was icatibant.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 3, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03888755
PeptideScanner retained ClinicalTrials.gov record NCT03888755 at 2026-11-15T22:04:12.435Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was icatibant.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 3, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Icatibant · 2026-08-07
ClinicalTrials.gov record NCT05509569
Completed at the retained observation.
Open attributed record →Icatibant · 2025-02-21
ClinicalTrials.gov record NCT04057131
Completed at the retained observation.
Open attributed record →Icatibant · 2021-06-08
ClinicalTrials.gov record NCT01386658
Completed at the retained observation.
Open attributed record →Icatibant · 2021-06-03
ClinicalTrials.gov record NCT02045264
Completed at the retained observation.
Open attributed record →Icatibant · 2021-06-03
ClinicalTrials.gov record NCT03888755
Completed at the retained observation.
Open attributed record →